Skip to contentI
Innoviva, Inc.
I
INVAInnoviva, Inc. Q2 2023 · 10-Q
Revenue$80.99M$80.99M−25.2% vs Q2 2022 Net Income$1.28M$1.28M−94.0% vs Q2 2022 EPS Diluted$0.02$0.02−60.0% vs Q2 2022 Operating Cash Flowderived$38,182,000−51.7% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Innoviva, Inc. · CIK 1080014 · Engraved from SEC EDGAR
Free Cash Flowderived$38,182,000−51.7% Margins · derivedNet margin1.6%−18.2 pt vs Q2 2022
ended Jun 30, 2023 · filed Aug 2, 2023 · 33 d after period end